Comparison of different types of cardiac amyloidosis by cardiac magnetic resonance imaging. (June 2015)
- Record Type:
- Journal Article
- Title:
- Comparison of different types of cardiac amyloidosis by cardiac magnetic resonance imaging. (June 2015)
- Main Title:
- Comparison of different types of cardiac amyloidosis by cardiac magnetic resonance imaging
- Authors:
- Kristen, Arnt V.
aus dem Siepen, Fabian
Scherer, Katrin
Kammerer, Rebekka
Andre, Florian
Buss, Sebastian J.
Bauer, Ralf
Lehrke, Stephanie
Voss, Andreas
Giannitsis, Evangelos
Katus, Hugo A.
Steen, Henning - Abstract:
- <abstract> <title>Abstract</title> <p> <italic>Objectives</italic>: We sought to determine cardiac morphological and functional differences between light-chain (AL), mutant-type transthyretin (ATTRmt) and wild-type TTR (ATTRwt) amyloidosis using contrast-enhancement cardiac magnetic resonance imaging (CE-CMR). Finally, we attempted to establish the diagnostic and prognostic impact of these findings. I<italic>ntroduction</italic>: The most common forms of cardiac amyloid are AL and ATTR amyloidosis, but the clinical courses of these variants are quite heterogeneous. While CE-CMR is used to evaluate patients with cardiac amyloidosis, its ability to predict prognosis in these patients is debatable.</p> <p> <italic>Methods</italic>: About 130 patients with cardiac amyloidosis (AL, <italic>n</italic> = 62; ATTRmt, <italic>n</italic> = 30, ATTRwt, <italic>n</italic> = 33) were assessed by CE-CMR (cardiac morphology, cardiac function, late gadolinium enhancement).</p> <p> <italic>Results</italic>: Left ventricular (LV) mass, basal and mid-ventricular maximal wall thickness, and thickness of the inter-atrial septum were higher in ATTRwt when compared to AL and ATTRmt amyloidosis. Tricuspid annular excursion was lower in ATTRwt amyloidosis than in AL amyloidosis. CE was observed in 94.6% of the patients (AL 80.6%; ATTRmt 90%; ATTRwt 87.9%) with significant differences in quality and intensity between the groups. Differentiation of amyloid types was achieved by combination of age,<abstract> <title>Abstract</title> <p> <italic>Objectives</italic>: We sought to determine cardiac morphological and functional differences between light-chain (AL), mutant-type transthyretin (ATTRmt) and wild-type TTR (ATTRwt) amyloidosis using contrast-enhancement cardiac magnetic resonance imaging (CE-CMR). Finally, we attempted to establish the diagnostic and prognostic impact of these findings. I<italic>ntroduction</italic>: The most common forms of cardiac amyloid are AL and ATTR amyloidosis, but the clinical courses of these variants are quite heterogeneous. While CE-CMR is used to evaluate patients with cardiac amyloidosis, its ability to predict prognosis in these patients is debatable.</p> <p> <italic>Methods</italic>: About 130 patients with cardiac amyloidosis (AL, <italic>n</italic> = 62; ATTRmt, <italic>n</italic> = 30, ATTRwt, <italic>n</italic> = 33) were assessed by CE-CMR (cardiac morphology, cardiac function, late gadolinium enhancement).</p> <p> <italic>Results</italic>: Left ventricular (LV) mass, basal and mid-ventricular maximal wall thickness, and thickness of the inter-atrial septum were higher in ATTRwt when compared to AL and ATTRmt amyloidosis. Tricuspid annular excursion was lower in ATTRwt amyloidosis than in AL amyloidosis. CE was observed in 94.6% of the patients (AL 80.6%; ATTRmt 90%; ATTRwt 87.9%) with significant differences in quality and intensity between the groups. Differentiation of amyloid types was achieved by combination of age, number of organs, the presence of inferolateral CE-CMR, thickness of inter-atrial septum and troponin T. Overall 1-year-survival rates were 93.3, 93.9 and 70.5% in ATTRwt, ATTRmt and AL amyloidosis, respectively. LV mass, mitral annular excursion and NT-proBNP in AL amyloidosis, LV mass maximal apical wall thickness and troponin T in ATTRwt amyloidosis, and finally NT-proBNP and renal function in ATTRmt amyloidosis were independent predictors of outcome.</p> <p> <italic>Conclusions</italic>: This study demonstrates that CE-CMR can highlight morphological and functional differences between different types of cardiac amyloidosis. In addition, CE-CMR and cardiac biomarkers provide useful prognostic information in patients with cardiac amyloidosis.</p> </abstract> … (more)
- Is Part Of:
- Amyloid. Volume 22:Number 2(2015:Jun.)
- Journal:
- Amyloid
- Issue:
- Volume 22:Number 2(2015:Jun.)
- Issue Display:
- Volume 22, Issue 2 (2015)
- Year:
- 2015
- Volume:
- 22
- Issue:
- 2
- Issue Sort Value:
- 2015-0022-0002-0000
- Page Start:
- 132
- Page End:
- 141
- Publication Date:
- 2015-06
- Subjects:
- Amyloidosis -- Periodicals
616.3995 - Journal URLs:
- http://informahealthcare.com/loi/amy ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/13506129.2015.1020153 ↗
- Languages:
- English
- ISSNs:
- 1350-6129
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0859.841173
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4190.xml